UA98296C2 - Pharmaceutical composition in the form of injection solution exhibiting cerebrovasodilating and nootropic activity, and method for the preparation thereof - Google Patents

Pharmaceutical composition in the form of injection solution exhibiting cerebrovasodilating and nootropic activity, and method for the preparation thereof

Info

Publication number
UA98296C2
UA98296C2 UAA200808719A UAA200808719A UA98296C2 UA 98296 C2 UA98296 C2 UA 98296C2 UA A200808719 A UAA200808719 A UA A200808719A UA A200808719 A UAA200808719 A UA A200808719A UA 98296 C2 UA98296 C2 UA 98296C2
Authority
UA
Ukraine
Prior art keywords
cerebrovasodilating
pharmaceutical composition
injection solution
preparation
nootropic activity
Prior art date
Application number
UAA200808719A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Мераб Ревазович Кокеладзе
Original Assignee
Закрытое Акционерное Общество "Канонфарма Продакшн"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое Акционерное Общество "Канонфарма Продакшн" filed Critical Закрытое Акционерное Общество "Канонфарма Продакшн"
Publication of UA98296C2 publication Critical patent/UA98296C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention provides a pharmaceutical composition that exhibits cerebrovasodilating and nootropic activity, is made in the form of injection solution with pH not above 4.0 and comprises vinpocetine, pyracetam, water for injections, succinic acid and/or ascorbic acid or glycine, sodium metabisulfite and/or sodium succinate, and/or sodium chloride, and/or sodium acetate in specified ratio of components.
UAA200808719A 2007-10-17 2008-07-02 Pharmaceutical composition in the form of injection solution exhibiting cerebrovasodilating and nootropic activity, and method for the preparation thereof UA98296C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2007138661/15A RU2359669C1 (en) 2007-10-17 2007-10-17 Pharmaceutical composition in form of solution for injections, possessing cerebrovasodilating and nootropic activity, and method of its reception

Publications (1)

Publication Number Publication Date
UA98296C2 true UA98296C2 (en) 2012-05-10

Family

ID=40852072

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200808719A UA98296C2 (en) 2007-10-17 2008-07-02 Pharmaceutical composition in the form of injection solution exhibiting cerebrovasodilating and nootropic activity, and method for the preparation thereof

Country Status (3)

Country Link
EA (1) EA014879B1 (en)
RU (1) RU2359669C1 (en)
UA (1) UA98296C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102160853A (en) * 2011-02-11 2011-08-24 方宝林 Vinpocetine injection and preparation method thereof
EA035073B1 (en) * 2017-11-22 2020-04-24 Открытое акционерное общество "Авексима" Pharmaceutical composition having nootropic activity in the form of a rapidly dissolving effervescent tablet, and method for preparation thereof
CN116139076A (en) * 2021-11-23 2023-05-23 珠海和凡医药股份有限公司 Preparation method of piracetam injection and piracetam injection prepared by preparation method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126250C1 (en) * 1997-10-20 1999-02-20 Ставропольская государственная медицинская академия Method of treating psycho-pathological syndromes of boundary level of vasculosclerotic genesis
RU2224514C2 (en) * 2002-05-07 2004-02-27 Закрытое акционерное общество "Брынцалов - А" Nootropic agent "nootobril" as injection solution
RU2232579C1 (en) * 2002-12-16 2004-07-20 Открытое акционерное общество "Биохимик" Vinpocetin solution
RU2262931C2 (en) * 2003-11-03 2005-10-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Pharmaceutical composition possessing cerebrovasodilating and nootropic activity

Also Published As

Publication number Publication date
RU2359669C1 (en) 2009-06-27
EA014879B1 (en) 2011-02-28
EA200801299A1 (en) 2009-04-28

Similar Documents

Publication Publication Date Title
AR063150A1 (en) STABLE FORMULATIONS
EP2175834B8 (en) Glp-1-fc fusion protein formulation
TNSN07020A1 (en) Her2 antibody composition
MX2009006594A (en) Formulations.
DE602007006419D1 (en) METHOD OF USE OF GUAVA EXTRACT AND COMPOSITION WITH GUAVA EXTRACT
ATE494902T1 (en) A CHICKEN GNRH-II ANALOG FOR USE IN REDUCING TUMOR CELL GROWTH
EA200801460A1 (en) Recombinant Monovalent Antibodies and Methods for Their Production
ATE495739T1 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING LEVODOPA AND CARBIDOPA
RU2009148286A (en) LIQUID PHARMACEUTICAL COMPOSITION OF BOTULIN TOXIN
TNSN08511A1 (en) Lyophilized formulations of anti-egfr antibodies
UA96473C2 (en) Liquid stable formulation comprising imc-a12 antibody
DK1842557T3 (en) Drug carrier and drug carrier kit for inhibiting fibrosis
WO2004089396A3 (en) Anti-fungal peptidomimetics
SG178797A1 (en) Oligosaccharide chain added glp-1 peptide
EA200700976A1 (en) COMPOUNDS IN THE FORM OF MOLECULE-CONJUGATES, HAVING ENHANCED ACTIVITY WITH RESPECT TO THE INCLUSION OF CELL
RS52867B (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
SG162744A1 (en) Stable active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
EA200601288A1 (en) 1,3-DIPHENYLPROP-2-EN-1-SHE DERIVATIVES, METHOD OF THEIR RECEIVING AND APPLICATION
RS53089B (en) Treatments for neurological disorders
BRPI0519209A2 (en) organic compounds
ATE533488T1 (en) METHODS AND FORMULATIONS FOR MODULATING LYN KINASE ACTIVITY AND TREATING ASSOCIATED DISEASES
WO2007092343A3 (en) Novel epoprostenol formulation and method of making thereof
MX2010000997A (en) Pharmaceutical combinations comprising a tyrosine kinase inhibitor and an antibody against integrin alpha 1 beta 5 (cd49e).
BRPI0720230A2 (en) USE OF AN ORALLY ADMINISTRATIVE NUTRITIONAL FORMULATION, NUTRITIONAL FORMULATION, METHOD FOR TREATING A PENETRANTING DEVELOPMENT DISTURBANCE, AND
UA98296C2 (en) Pharmaceutical composition in the form of injection solution exhibiting cerebrovasodilating and nootropic activity, and method for the preparation thereof